CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit

NEW YORK, March 16, 2026 /PRNewswire/ —

More Stories

Elliott Management Statement on Mitsui O.S.K. Lines, Ltd.

LONDON, March 17, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant investment in Mitsui O.S.K. Lines, Ltd. (“Mitsui O.S.K.” or the “Company”), today issued the following statement:

Read More »